| DTBRX | GIBLX | DTBRX / GIBLX | |
| Total Expense Ratio | 1.01 | 0.85 | 119% |
| Annual Report Gross Expense Ratio | 1.28 | 0.91 | 141% |
| Fund Existence | 18 years | 11 years | - |
| Gain YTD | 6.609 | 7.348 | 90% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 52B | 30.1B | 173% |
| Annual Yield % from dividends | 4.04 | 4.71 | 86% |
| Returns for 1 year | 6.63 | 7.50 | 88% |
| Returns for 3 years | 17.54 | 20.39 | 86% |
| Returns for 5 years | -2.35 | -2.05 | 114% |
| Returns for 10 years | 18.77 | 29.17 | 64% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BUXX | 20.30 | 0.01 | +0.02% |
| Strive Enhanced Income Short MaturityETF | |||
| BIB | 74.47 | -1.60 | -2.10% |
| ProShares Ultra Nasdaq Biotechnology | |||
| IAI | 175.04 | -4.25 | -2.37% |
| iShares US Broker-Dealers&Secs Exchs ETF | |||
| CTEX | 34.95 | -2.73 | -7.24% |
| ProShares S&P Kensho Cleantech ETF | |||
| AVGG | 28.12 | -2.77 | -8.95% |
| Leverage Shares 2X Long AVGO Daily ETF | |||